Shorter radiation beats standard for prostate cancer?
NCT ID NCT07489729
First seen Apr 05, 2026 · Last updated May 16, 2026 · Updated 10 times
Summary
This study looked at 60 men with intermediate- or high-risk prostate cancer to compare two radiation therapy approaches: a shorter course (hypofractionated) versus the standard longer course. All men also received hormone therapy. The goal was to see which method better controls cancer, based on PSA levels and tumor response, while also tracking side effects. Results help doctors choose the best treatment plan.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER PATIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tanta University
Tanta, Egypt
Conditions
Explore the condition pages connected to this study.